Intrauterine Contraception After First Trimester Abortion - Effects on Quality of Life and Risk of Repeat Abortion.
|ClinicalTrials.gov Identifier: NCT01223521|
Recruitment Status : Active, not recruiting
First Posted : October 19, 2010
Last Update Posted : January 17, 2018
|Condition or disease||Intervention/treatment||Phase|
|Contraception||Device: Immediate intrauterine contraception||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||700 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Triple (Participant, Care Provider, Investigator)|
|Official Title:||Systematic Provision of Intrauterine Contraception After First Trimester Abortion - Effects on Quality of Life and Risk of Repeat Abortion. A Randomized, Prospective Trial.|
|Study Start Date :||September 2010|
|Estimated Primary Completion Date :||March 2018|
|Estimated Study Completion Date :||March 2018|
Experimental: Immediate intrauterine contraception
IUD (either Cu-IUD or LNG-IUS) inserted immediately after abortion.
Device: Immediate intrauterine contraception
A Cu-IUD or LNG-IUS is inserted after abortion.
No Intervention: Control group
Post-abortal contraception is prescribed by the hospital but on the responsibility of the patient.
- Number of repeat abortions [ Time Frame: 5 years ]Number of subsequent abortions during five years follow-up time.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01223521
|Dept Obstetrics and Gynecology, Helsinki University Central Hospital|
|Helsinki, Finland, 00029 HUS|
|Principal Investigator:||Oskari Heikinheimo, MD, PhD||Helsinki University Central Hospital|
|Study Director:||Satu P Suhonen, MD, PhD||City of Helsinki|